Literature DB >> 17674488

Synthesis and anticonvulsant activity of some potent 5,6-bis aryl 1,2,4-triazines.

B P Mallikarjuna1, G V Suresh Kumar, B S Sastry, K P Manohara.   

Abstract

In the present research, a series of 5,6-bis aryl 1,2,4-triazines 5a~5f were synthesized by condensation of various benzils 4a~4f with aminoguanidine bicarbonate and were screened in vivo, for their anticonvulsant and neurotoxicity studies. Compounds 5a, 5b and 5d were found to be potent molecules of this series, when compared with the reference drugs phenytoin sodium, diazepam and lamotrigine. The structures of these compounds were established by IR, (1)H NMR, (13)C NMR and mass spectroscopic data.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674488      PMCID: PMC1906601          DOI: 10.1631/jzus.2007.b0526

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  10 in total

Review 1.  Epilepsy.

Authors:  Bernard S Chang; Daniel H Lowenstein
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

2.  Behavioural despair in rats: a new model sensitive to antidepressant treatments.

Authors:  R D Porsolt; G Anton; N Blavet; M Jalfre
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

3.  Antimalarial activities of some 3,5-diamino-as-triazine derivatives.

Authors:  R W Rees; P B Russell; T J Foell; R E Bright
Journal:  J Med Chem       Date:  1972-08       Impact factor: 7.446

Review 4.  Animal models of the epilepsies.

Authors:  R S Fisher
Journal:  Brain Res Brain Res Rev       Date:  1989 Jul-Sep

5.  Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones.

Authors:  S N Pandeya; P Yogeeswari; J P Stables
Journal:  Eur J Med Chem       Date:  2000-10       Impact factor: 6.514

6.  Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.

Authors:  D A Hosford; Y Wang
Journal:  Epilepsia       Date:  1997-04       Impact factor: 5.864

7.  Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain.

Authors:  O A Petroff; D L Rothman; K L Behar; R H Mattson
Journal:  Epilepsia       Date:  1995-05       Impact factor: 5.864

8.  Comparative anticonvulsant potency and pharmacokinetics of (+)-and (-)-enantiomers of stiripentol.

Authors:  D D Shen; R H Levy; J L Savitch; A V Boddy; F Tombret; F Lepage
Journal:  Epilepsy Res       Date:  1992-06       Impact factor: 3.045

Review 9.  Some aspects of prognosis in the epilepsies: a review.

Authors:  J W Sander
Journal:  Epilepsia       Date:  1993 Nov-Dec       Impact factor: 5.864

Review 10.  The promise of new antiepileptic drugs.

Authors:  John S Duncan
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.